Medications

New strategies reduce treatment failure in malaria by up to 81%

Artemisinin-based combination therapies (ACTs) are the globally-accepted first-line treatments for malaria—a mosquito-borne disease caused by the Plasmodium falciparum parasite that annually kills around 600,000 people, ...

Diseases, Conditions, Syndromes

The search for a malaria vaccine

Our battle with malaria has lasted thousands of years. We need better vaccines or we risk losing, according to UNSW Sydney researchers.

Diseases, Conditions, Syndromes

Monoclonal antibody prevents malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found. The antibody ...

page 1 from 11